Harvard Bioscience, Inc. (HBIO)
USD 2.03
(-6.45%)
USD 2.03
(-6.45%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 42.77 Million USD | -8.65% |
| 2022 | 46.82 Million USD | -3.12% |
| 2021 | 48.33 Million USD | 0.67% |
| 2020 | 48 Million USD | -10.8% |
| 2019 | 53.81 Million USD | -11.48% |
| 2018 | 60.79 Million USD | 417.49% |
| 2017 | 11.74 Million USD | -14.54% |
| 2016 | 13.74 Million USD | -27.27% |
| 2015 | 18.9 Million USD | -11.89% |
| 2014 | 21.45 Million USD | -13.33% |
| 2013 | 24.75 Million USD | 91.12% |
| 2012 | 12.95 Million USD | -20.55% |
| 2011 | 16.3 Million USD | -9.51% |
| 2010 | 18.01 Million USD | 35.22% |
| 2009 | 13.32 Million USD | 838.1% |
| 2008 | 1.42 Million USD | -81.67% |
| 2007 | 7.74 Million USD | 158.23% |
| 2006 | 3 Million USD | -64.79% |
| 2005 | 8.52 Million USD | -48.48% |
| 2004 | 16.54 Million USD | 25.44% |
| 2003 | 13.18 Million USD | 1099.8% |
| 2002 | 1.09 Million USD | -75.75% |
| 2001 | 4.53 Million USD | 58097.29% |
| 2000 | 7786.00 USD | -99.9% |
| 1999 | 8.06 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 41.36 Million USD | -3.29% |
| 2024 Q2 | 41.45 Million USD | 0.21% |
| 2023 Q2 | 41.42 Million USD | -5.97% |
| 2023 Q3 | 38.74 Million USD | -6.47% |
| 2023 Q4 | 42.77 Million USD | 10.4% |
| 2023 Q1 | 44.05 Million USD | -5.92% |
| 2023 FY | 42.77 Million USD | -8.65% |
| 2022 Q4 | 46.82 Million USD | -4.93% |
| 2022 FY | 46.82 Million USD | -3.12% |
| 2022 Q1 | 57.27 Million USD | 18.51% |
| 2022 Q2 | 56.39 Million USD | -1.53% |
| 2022 Q3 | 49.25 Million USD | -12.67% |
| 2021 Q3 | 45.21 Million USD | -13.35% |
| 2021 FY | 48.33 Million USD | 0.67% |
| 2021 Q1 | 52.78 Million USD | 9.96% |
| 2021 Q2 | 52.17 Million USD | -1.17% |
| 2021 Q4 | 48.33 Million USD | 6.9% |
| 2020 Q1 | 49.08 Million USD | -8.79% |
| 2020 Q2 | 43.72 Million USD | -10.92% |
| 2020 Q3 | 43.47 Million USD | -0.58% |
| 2020 Q4 | 48 Million USD | 10.42% |
| 2020 FY | 48 Million USD | -10.8% |
| 2019 FY | 53.81 Million USD | -11.48% |
| 2019 Q2 | 65.83 Million USD | -2.76% |
| 2019 Q1 | 67.7 Million USD | 11.36% |
| 2019 Q4 | 53.81 Million USD | -0.92% |
| 2019 Q3 | 54.31 Million USD | -17.49% |
| 2018 Q1 | 62.98 Million USD | 436.11% |
| 2018 FY | 60.79 Million USD | 417.49% |
| 2018 Q4 | 60.79 Million USD | -0.41% |
| 2018 Q3 | 61.04 Million USD | -0.66% |
| 2018 Q2 | 61.44 Million USD | -2.43% |
| 2017 FY | 11.74 Million USD | -14.54% |
| 2017 Q3 | 12.43 Million USD | -5.74% |
| 2017 Q2 | 13.19 Million USD | -3.35% |
| 2017 Q1 | 13.65 Million USD | -0.68% |
| 2017 Q4 | 11.74 Million USD | -5.56% |
| 2016 Q1 | 17.14 Million USD | -9.27% |
| 2016 FY | 13.74 Million USD | -27.27% |
| 2016 Q3 | 15.04 Million USD | -6.94% |
| 2016 Q2 | 16.16 Million USD | -5.74% |
| 2016 Q4 | 13.74 Million USD | -8.62% |
| 2015 Q3 | 20.15 Million USD | -2.42% |
| 2015 Q1 | 21.9 Million USD | 2.1% |
| 2015 FY | 18.9 Million USD | -11.89% |
| 2015 Q2 | 20.65 Million USD | -5.71% |
| 2015 Q4 | 18.9 Million USD | -6.2% |
| 2014 Q3 | 23.2 Million USD | 4.27% |
| 2014 Q2 | 22.25 Million USD | -5.32% |
| 2014 Q4 | 21.45 Million USD | -7.54% |
| 2014 Q1 | 23.5 Million USD | -5.05% |
| 2014 FY | 21.45 Million USD | -13.33% |
| 2013 FY | 24.75 Million USD | 91.12% |
| 2013 Q4 | 24.75 Million USD | 5.32% |
| 2013 Q3 | 23.5 Million USD | -3.09% |
| 2013 Q2 | 24.25 Million USD | 61.67% |
| 2013 Q1 | 15 Million USD | 15.83% |
| 2012 Q2 | 16.1 Million USD | -4.17% |
| 2012 Q3 | 15.3 Million USD | -4.97% |
| 2012 Q1 | 16.8 Million USD | 3.07% |
| 2012 Q4 | 12.95 Million USD | -15.36% |
| 2012 FY | 12.95 Million USD | -20.55% |
| 2011 FY | 16.3 Million USD | -9.51% |
| 2011 Q4 | 16.3 Million USD | -0.03% |
| 2011 Q3 | 16.3 Million USD | -4.69% |
| 2011 Q2 | 17.1 Million USD | -0.02% |
| 2011 Q1 | 17.11 Million USD | -5.01% |
| 2010 Q1 | 11.81 Million USD | -11.32% |
| 2010 Q2 | 11.15 Million USD | -5.54% |
| 2010 Q3 | 18.01 Million USD | 61.41% |
| 2010 FY | 18.01 Million USD | 35.22% |
| 2010 Q4 | 18.01 Million USD | 0.01% |
| 2009 Q3 | 9.03 Million USD | 1595.68% |
| 2009 Q1 | 963 Thousand USD | -32.18% |
| 2009 FY | 13.32 Million USD | 838.1% |
| 2009 Q4 | 13.32 Million USD | 47.39% |
| 2009 Q2 | 533 Thousand USD | -44.65% |
| 2008 Q3 | 2.2 Million USD | 4.89% |
| 2008 Q1 | 2.31 Million USD | -70.14% |
| 2008 FY | 1.42 Million USD | -81.67% |
| 2008 Q4 | 1.42 Million USD | -35.72% |
| 2008 Q2 | 2.1 Million USD | -8.95% |
| 2007 FY | 7.74 Million USD | 158.23% |
| 2007 Q4 | 7.74 Million USD | 175.99% |
| 2007 Q3 | 2.8 Million USD | 1303.5% |
| 2007 Q2 | 200 Thousand USD | -86.67% |
| 2007 Q1 | 1.5 Million USD | -50.0% |
| 2006 Q4 | 3 Million USD | 0.0% |
| 2006 FY | 3 Million USD | -64.79% |
| 2006 Q3 | 3 Million USD | -53.85% |
| 2006 Q2 | 6.5 Million USD | -23.69% |
| 2006 Q1 | 8.51 Million USD | -0.04% |
| 2005 Q4 | 8.52 Million USD | -41.33% |
| 2005 Q2 | 15.22 Million USD | -0.05% |
| 2005 Q3 | 14.52 Million USD | -4.62% |
| 2005 FY | 8.52 Million USD | -48.48% |
| 2005 Q1 | 15.23 Million USD | -7.89% |
| 2004 FY | 16.54 Million USD | 25.44% |
| 2004 Q4 | 16.54 Million USD | -6.79% |
| 2004 Q3 | 17.74 Million USD | -2.25% |
| 2004 Q1 | 19.78 Million USD | 50.04% |
| 2004 Q2 | 18.15 Million USD | -8.23% |
| 2003 Q3 | 432 Thousand USD | -93.46% |
| 2003 FY | 13.18 Million USD | 1099.8% |
| 2003 Q1 | 7.04 Million USD | 540.87% |
| 2003 Q2 | 6.6 Million USD | -6.16% |
| 2003 Q4 | 13.18 Million USD | 2952.19% |
| 2002 Q1 | 4.42 Million USD | -2.41% |
| 2002 FY | 1.09 Million USD | -75.75% |
| 2002 Q2 | 798 Thousand USD | -81.95% |
| 2002 Q4 | 1.09 Million USD | 1.19% |
| 2002 Q3 | 1.08 Million USD | 36.09% |
| 2001 FY | 4.53 Million USD | 58097.29% |
| 2001 Q2 | 45 Thousand USD | 650.0% |
| 2001 Q3 | 44 Thousand USD | -2.22% |
| 2001 Q1 | 6000.00 USD | -22.94% |
| 2001 Q4 | 4.53 Million USD | 10198.28% |
| 2000 FY | 7786.00 USD | -99.9% |
| 2000 Q4 | 7786.00 USD | 0.0% |
| 1999 FY | 8.06 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 50.093% |
| AngioDynamics, Inc. | 5.91 Million USD | -623.25% |
| AtriCure, Inc. | 74.49 Million USD | 42.582% |
| Avinger, Inc. | 15.39 Million USD | -177.837% |
| Azenta, Inc. | 60.43 Million USD | 29.226% |
| BioLife Solutions, Inc. | 42.69 Million USD | -0.192% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 98.335% |
| Daxor Corporation | 755.65 Thousand USD | -5560.357% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -496.722% |
| Femasys Inc. | 6.7 Million USD | -538.319% |
| GlucoTrack, Inc. | 196 Thousand USD | -21722.959% |
| Hologic, Inc. | 2.53 Billion USD | 98.312% |
| ICU Medical, Inc. | 1.7 Billion USD | 97.491% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 52.369% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -862.246% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | -124.001% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 95.59% |
| Microbot Medical Inc. | 231 Thousand USD | -18416.45% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -483.443% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 95.201% |
| Nephros, Inc. | 1.83 Million USD | -2229.684% |
| NovoCure Limited | 596.24 Million USD | 92.826% |
| NEXGEL, Inc. | 2.79 Million USD | -1428.699% |
| NEXGEL, Inc. | 2.79 Million USD | -1428.699% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 43.187% |
| OraSure Technologies, Inc. | 13.5 Million USD | -216.743% |
| Pro-Dex, Inc. | 13.54 Million USD | -215.738% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -367.771% |
| Predictive Oncology Inc. | 2.85 Million USD | -1397.227% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -1145.406% |
| QuidelOrtho Corporation | 2.61 Billion USD | 98.364% |
| Repligen Corporation | 711.8 Million USD | 93.991% |
| Sanara MedTech Inc. | 11.79 Million USD | -262.726% |
| STAAR Surgical Company | 35.83 Million USD | -19.364% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -12406.725% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 98.139% |
| Jin Medical International Ltd. | 4.11 Million USD | -939.947% |